| Patient | Hatshepsut |
|---|---|
| Date of birth | 1978-02-10 |
| Identifiers | MRN HR-AC006-SYN; SSN (made up) 000-06-9440 |
| Document date | 2026-11-01 |
| Author | Amunet Okafor-Harrington, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for a painful swollen jaw from a suspected dental abscess, with diabetes found on screening; urgent oral and maxillofacial surgery referral. Concerns: Her jaw is swollen and throbbing and she cannot chew; she wants it treated quickly so she can keep her public engagements; She was surprised to hear she has diabetes and wants a plan she can keep with her schedule, without being lectured about her weight; Her knees hurt on stairs at the building sites. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Ibuprofen 400 mg oral tablet, one tablet by mouth every six hours as needed for dental pain, with food, for up to one week | One tablet every six hours as needed, with food; no more than four a day | Oral route | 2026-04-14 to 2026-04-22 | completed | S |
| Acetaminophen 500 mg oral tablet, two tablets (1 g) by mouth every six hours as needed for dental pain, alternating with ibuprofen, no more than 3 g a day, for up to one week | Two tablets every six hours as needed; no more than six a day | Oral route | 2026-04-14 to 2026-04-22 | completed | S |
| Metformin extended-release 500 mg tablet, one tablet with the evening meal for one week, then two tablets (1000 mg) with the evening meal | One tablet with the evening meal for a week, then two | Oral route | 2026-04-14 | active | S |
| Diclofenac sodium 1% gel, 4 g to each painful knee up to four times a day as needed | 4 g to each knee up to four times a day as needed | Topical route | 2026-04-14 | active | S |
| Chlorhexidine gluconate 0.12% oral rinse, 15 mL swished for 30 seconds and spat out twice daily for two weeks after the extraction | 15 mL rinse twice daily for two weeks | Oral route | 2026-04-15 to 2026-04-29 | completed | S |
| Semaglutide 0.25 mg subcutaneous injection once weekly (starting dose, planned for four weeks) | 0.25 mg once weekly | Subcutaneous route | 2026-05-26 to 2026-06-30 | completed | S |
| Semaglutide 0.5 mg subcutaneous injection once weekly (maintenance dose for now) | 0.5 mg once weekly | Subcutaneous route | 2026-06-30 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet by mouth daily | One tablet daily | Oral route | 2026-05-26 | active | S |
| Nitrofurantoin monohydrate/macrocrystals 100 mg capsule, one capsule by mouth twice daily with food for five days | One capsule twice daily with food for five days | Oral route | 2026-06-23 to 2026-06-28 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Panoramic radiograph (orthopantomogram) with a periapical film of the lower left molars | 2026-04-15 to 2026-04-15 | completed | S |
| Incision and drainage of the buccal vestibular abscess of tooth 19, intraoral approach, under local anesthesia | 2026-04-15 to 2026-04-15 | completed | S |
| Extraction of the non-restorable lower left first molar (tooth 19) under local anesthesia | 2026-04-15 to 2026-04-15 | completed | S |
| Advance care planning conversation, about 20 minutes | 2026-06-30 to 2026-06-30 | completed | S |
| Comprehensive diabetic foot examination with 10-g monofilament, vibration and pulses | 2026-05-26 to 2026-05-26 | completed | S |
| Retinal photography of both eyes, read by an ophthalmologist | 2026-05-26 to 2026-05-26 | completed | S |
| Scaling and root planing of all teeth by the dental team, under local anesthesia, over two appointments | 2026-06-09 to 2026-06-09 | completed | S |
| Screening mammography, both breasts | 2026-07-14 to 2026-07-14 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2026-06-30 | Pneumococcal conjugate vaccine, 20-valent (PCV20), single dose for an adult with diabetes | completed | S |
| 2026-06-30 | Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) | completed | S |
| 2026-06-30 | Hepatitis B vaccine (HepB-CpG), dose 1 of 2 | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
No historical medical events are recorded.
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| Her jaw is swollen and throbbing and she cannot chew; she wants it treated quickly so she can keep her public engagements | active | S |
| She was surprised to hear she has diabetes and wants a plan she can keep with her schedule, without being lectured about her weight | active | S |
| Her knees hurt on stairs at the building sites | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 13.1 on 2026-04-14; Leukocytes [#/volume] in Blood by Automated count 11.6 on 2026-04-14; Platelets [#/volume] in Blood by Automated count 312 on 2026-04-14; Sodium [Moles/volume] in Serum or Plasma 137 on 2026-04-14; Potassium [Moles/volume] in Serum or Plasma 4.2 on 2026-04-14; Urea nitrogen [Mass/volume] in Serum or Plasma 13 on 2026-04-14; Creatinine [Mass/volume] in Serum or Plasma 0.72 on 2026-04-14; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 103 on 2026-04-14; Glucose [Mass/volume] in Serum or Plasma 212 on 2026-04-14; Calcium [Mass/volume] in Serum or Plasma 9.4 on 2026-04-14; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 27 on 2026-07-21; Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 84 on 2026-04-14; Hemoglobin A1c/Hemoglobin.total in Blood 6.6 on 2026-07-21; Cholesterol [Mass/volume] in Serum or Plasma 152 on 2026-07-21; Cholesterol in HDL [Mass/volume] in Serum or Plasma 48 on 2026-07-21; Triglyceride [Mass/volume] in Serum or Plasma 140 on 2026-07-21; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 76 on 2026-07-21; Albumin/Creatinine [Mass Ratio] in Urine 18 on 2026-04-14; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 2026-04-14; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 2026-07-21; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 on 2026-04-14; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-06-30; Total score [AUDIT-C] 1 on 2026-06-30 [S]
Strengths and supports: Lives in the city with household staff; has an adult child. Supports: a small circle of trusted advisers, her household, and work she cares about [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Painful swelling of the left lower jaw for four days, after a throbbing toothache for three weeks under a broken lower left molar; low-grade temperature, no trismus, no swelling of the floor of the mouth or neck; dental abscess suspected | resolved | confirmed | R68.84 | S — Synthetic presenting concern at the index visit, superseded by the dental diagnosis the next day. It echoes the dental disease reported on the mummy identified as hers (R, after the index date), without linking to it. |
| Acute periapical abscess of the lower left first molar (tooth 19), non-restorable, with a localized buccal vestibular swelling and no spread to fascial spaces; drained and extracted | resolved | confirmed | K04.7 | S — Synthetic modern diagnosis; no historical claim is made. |
| Type 2 diabetes found on screening (hemoglobin A1c 7.6% with a random glucose of 212 mg/dL from the same sample), with thirst and waking at night to pass urine; normal kidney function and urine albumin | active | confirmed | E11.65 | S — Synthetic screening finding at intake; not linked to the disputed claim of diabetes on the mummy (R). |
| Obesity, class 2 (BMI 36.3), with type 2 diabetes and knee osteoarthritis; she wants to feel stronger and move more easily | active | confirmed | E66.812 | S — Synthetic finding at intake, recorded in person-first language. |
| Primary osteoarthritis of both knees: pain on stairs and after standing, morning stiffness under 30 minutes, crepitus, no effusion; a clinical diagnosis without imaging | active | confirmed | M17.0 | S — Synthetic finding at intake; not linked to the osteoarthritis reported on the mummy (R). |
| Periodontitis, generalized, stage III, grade C (bone loss to the middle third of the roots, two molars lost earlier to gum disease, and A1c above 7% as a grade modifier) | active | confirmed | K05.323 | S — Synthetic finding at the dental consultation. |
| Acute uncomplicated cystitis (dysuria and frequency for two days, urine dipstick positive for leukocyte esterase and nitrite, no fever or flank pain); urine culture grew Escherichia coli sensitive to nitrofurantoin; resolved | resolved | confirmed | N30.00 | S — Synthetic intercurrent illness; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-14 | Hemoglobin [Mass/volume] in Blood | 13.1 | g/dL | 11.7-15.5 g/dL | Normal | S |
| 2026-04-14 | Leukocytes [#/volume] in Blood by Automated count | 11.6 | 10*3/uL | 4-11 10*3/uL | High | S |
| 2026-04-14 | Platelets [#/volume] in Blood by Automated count | 312 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-04-14 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-04-14 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-04-14 | Urea nitrogen [Mass/volume] in Serum or Plasma | 13 | mg/dL | 7-20 mg/dL | Normal | S |
| 2026-04-14 | Creatinine [Mass/volume] in Serum or Plasma | 0.72 | mg/dL | 0.5-1.1 mg/dL | Normal | S |
| 2026-04-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 103 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-04-14 | Glucose [Mass/volume] in Serum or Plasma | 212 | mg/dL | 70-139 mg/dL | High | S |
| 2026-04-14 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-04-14 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 31 | U/L | 7-35 U/L | Normal | S |
| 2026-04-14 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 84 | U/L | 35-104 U/L | Normal | S |
| 2026-04-14 | Hemoglobin A1c/Hemoglobin.total in Blood | 7.6 | % | Below 5.7% is normal; 6.5% or more is diabetes; goal below 7% for most adults with diabetes | High | S |
| 2026-04-14 | Cholesterol [Mass/volume] in Serum or Plasma | 214 | mg/dL | <=199 mg/dL | High | S |
| 2026-04-14 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=50 mg/dL | Low | S |
| 2026-04-14 | Triglyceride [Mass/volume] in Serum or Plasma | 210 | mg/dL | <=149 mg/dL | High | S |
| 2026-04-14 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 128 | mg/dL | Goal below 100 mg/dL in diabetes, below 70 mg/dL at higher risk | Normal | S |
| 2026-04-14 | Albumin/Creatinine [Mass Ratio] in Urine | 18 | mg/g{creat} | <=29 mg/g{creat} | Normal | S |
| 2026-04-14 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 2026-04-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 2026-04-14 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 3 | {score} | S | ||
| 2026-07-21 | Hemoglobin A1c/Hemoglobin.total in Blood | 6.6 | % | Below 5.7% is normal; 6.5% or more is diabetes; goal below 7% for most adults with diabetes | High | S |
| 2026-07-21 | Cholesterol [Mass/volume] in Serum or Plasma | 152 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-07-21 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 48 | mg/dL | >=50 mg/dL | Low | S |
| 2026-07-21 | Triglyceride [Mass/volume] in Serum or Plasma | 140 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-07-21 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 76 | mg/dL | Goal below 100 mg/dL in diabetes, below 70 mg/dL at higher risk | Normal | S |
| 2026-07-21 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 27 | U/L | 7-35 U/L | Normal | S |
| 2026-07-21 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S | ||
| 2026-06-30 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-06-30 | Total score [AUDIT-C] | 1 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-04-14 | Body height | 160 | cm | S |
| 2026-04-14 | Body weight | 93 | kg | S |
| 2026-04-14 | Body mass index (BMI) [Ratio] | 36.3 | kg/m2 | S |
| 2026-04-14 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-04-14 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-04-14 | Heart rate | 92 | /min | S |
| 2026-04-14 | Respiratory rate | 16 | /min | S |
| 2026-04-14 | Body temperature | 37.6 | Cel | S |
| 2026-04-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-04-15 | Body height | 160 | cm | S |
| 2026-04-15 | Body weight | 92.8 | kg | S |
| 2026-04-15 | Body mass index (BMI) [Ratio] | 36.2 | kg/m2 | S |
| 2026-04-15 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-04-15 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-04-15 | Heart rate | 88 | /min | S |
| 2026-04-15 | Respiratory rate | 16 | /min | S |
| 2026-04-15 | Body temperature | 37.4 | Cel | S |
| 2026-04-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-05-26 | Body height | 160 | cm | S |
| 2026-05-26 | Body weight | 91.5 | kg | S |
| 2026-05-26 | Body mass index (BMI) [Ratio] | 35.7 | kg/m2 | S |
| 2026-05-26 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-05-26 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-05-26 | Heart rate | 78 | /min | S |
| 2026-05-26 | Respiratory rate | 14 | /min | S |
| 2026-05-26 | Body temperature | 36.7 | Cel | S |
| 2026-05-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-07-21 | Body height | 160 | cm | S |
| 2026-07-21 | Body weight | 88.6 | kg | S |
| 2026-07-21 | Body mass index (BMI) [Ratio] | 34.6 | kg/m2 | S |
| 2026-07-21 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-07-21 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-07-21 | Heart rate | 74 | /min | S |
| 2026-07-21 | Respiratory rate | 14 | /min | S |
| 2026-07-21 | Body temperature | 36.6 | Cel | S |
| 2026-07-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-06-23 | Body height | 160 | cm | S |
| 2026-06-23 | Body weight | 90.4 | kg | S |
| 2026-06-23 | Body mass index (BMI) [Ratio] | 35.3 | kg/m2 | S |
| 2026-06-23 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-06-23 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-06-23 | Heart rate | 84 | /min | S |
| 2026-06-23 | Respiratory rate | 16 | /min | S |
| 2026-06-23 | Body temperature | 37.2 | Cel | S |
| 2026-06-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 2026-06-30 | Body height | 160 | cm | S |
| 2026-06-30 | Body weight | 90 | kg | S |
| 2026-06-30 | Body mass index (BMI) [Ratio] | 35.2 | kg/m2 | S |
| 2026-06-30 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-06-30 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-06-30 | Heart rate | 76 | /min | S |
| 2026-06-30 | Respiratory rate | 14 | /min | S |
| 2026-06-30 | Body temperature | 36.6 | Cel | S |
| 2026-06-30 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-04-14 | New patient visit for a painful swollen jaw from a suspected dental abscess, with diabetes found on screening; urgent oral and maxillofacial surgery referral | finished | S |
| 2026-04-15 | Oral and maxillofacial surgery consultation with drainage and extraction of the abscessed molar, diagnosis of periodontitis, and diabetes review | finished | S |
| 2026-05-26 | Six-week review: healing, diabetes, cardiovascular risk, eye and foot screening, and the start of semaglutide | finished | S |
| 2026-07-21 | Fourteen-week review: A1c, lipids, weight, periodontal therapy, knees, and screening results | finished | S |
| 2026-06-23 | Same-day sick visit for acute cystitis in a woman with new type 2 diabetes | finished | S |
| 2026-06-30 | Periodic adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Dental pain and infection safety today: ibuprofen 400 mg with acetaminophen 1 g, alternating, for up to a week, and no opioid; no antibiotic, because the swelling is localized, there is no fever above 38 °C, no trismus and no spread, and drainage is arranged within 24 hours; go to the emergency department at once for swelling spreading to the eye, the floor of the mouth or the neck, difficulty swallowing or breathing, trouble opening the mouth, or a fever | completed | GL-ADA-DENT-PAIN-2024, GL-ADA-DENT-ABX-2019 | S |
| Urgent oral and maxillofacial surgery consultation within 24 hours for imaging, drainage of the abscess and extraction or other definitive treatment of the broken molar, with an assessment of her gums | completed | GL-ADA-DENT-ABX-2019, GL-EFP-IDF-2018 | S |
| Type 2 diabetes: metformin extended-release, started slowly; diabetes self-management education and medical nutrition therapy in the clinic's program; A1c every three months until at goal; eye screening, a comprehensive foot examination and kidney tests at diagnosis and yearly; blood pressure goal below 130/80; sick-day rules for metformin; endocrinology only if the A1c is not at goal by six months | completed | GL-ADA-2026, GL-CMID-2026 | S |
| Weight and health without stigma: person-first language, weight discussed only with her permission, goals she sets for strength and movement, and the medicines that lower both glucose and weight (GLP-1 receptor agonists) explained for her to consider | completed | GL-ADA-OB-2026 | S |
| Knee osteoarthritis: a walking and strengthening program, diclofenac gel as needed, and a cane or knee support for long site visits if helpful; no imaging needed for a clinical diagnosis | completed | GL-ACR-OA-2019, GL-CMID-2026 | S |
| Mood screening: PHQ-9 and GAD-7 at intake and at the end of the episode | completed | GL-USPSTF-DEP-2023 | S |
| Periodontitis and the abscess: chlorhexidine rinse for two weeks after the extraction; scaling and root planing of all teeth by the dental team about six weeks after the extraction, then periodontal maintenance every three months; the two-way link with diabetes explained (periodontal treatment can lower A1c, and better glucose control helps the gums heal) | completed | GL-EFP-IDF-2018, GL-AAP-EFP-2018 | S |
| Semaglutide once weekly, 0.25 mg for four weeks, then 0.5 mg, with small meals and stopping eating when full to limit nausea; chosen with her for glucose and weight after the dental infection had settled; an SGLT2 inhibitor is not indicated without kidney or heart disease; muscle-strengthening exercise and enough protein to protect muscle and bone as weight falls | completed | GL-ADA-2026, GL-ADA-OB-2026 | S |
| Cardiovascular risk: atorvastatin 20 mg daily (moderate intensity), as advised for adults 40 to 75 with diabetes; lipids and ALT at about eight to twelve weeks | completed | GL-ADA-CV-2026, GL-CMID-2026 | S |
| Acute cystitis: nitrofurantoin for five days after a urine culture; fluids; metformin continued while she eats and drinks normally, and paused if she vomits or cannot keep fluids down; the semaglutide step up to 0.5 mg delayed one week; return at once for fever, flank pain, vomiting or symptoms not better in 48 hours | completed | GL-IDSA-CYSTITIS-2011, GL-ADA-2026 | S |
| Cancer screening by age: screening mammography (every two years from 40), fecal immunochemical test yearly or colonoscopy (from 45), and primary HPV testing every five years (30 to 65); no search for bone cancer, because nothing in her history, examination or blood tests points to one; bone health through weight-bearing and strengthening exercise, calcium from food and adequate vitamin D, with bone density testing at 65 or sooner if a risk factor appears | completed | GL-USPSTF-BRCA-2024, GL-USPSTF-CRC-2021, GL-USPSTF-CERV-2018 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Dental infection drained and the tooth removed within 24 hours, with no spread of infection | 2026-04-15 | completed | Drained and extracted the next day; no spread | S |
| Hemoglobin A1c below 7% within four months | 2026-07-21 | completed | A1c 6.6% at fourteen weeks | S |
| LDL cholesterol below 100 mg/dL on a statin | 2026-07-21 | completed | LDL 76 mg/dL on atorvastatin | S |
| Periodontal therapy completed and three-monthly maintenance arranged | 2026-07-21 | completed | Scaling and root planing completed; maintenance every three months | S |
| Climb stairs at the building sites with less knee pain, and walk 150 minutes a week | 2026-07-21 | active | Walking about 120 minutes a week; knee pain on stairs eased | S |